Gala vs Maximus: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Maximus beats Gala overall, scoring 7.1/10 vs 7/10. Gala is more affordable at $149/mo vs $300/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Maximus for men who want glp-1 alongside testosterone or other men's hea.
A side-by-side comparison of Gala and Maximus covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaMaximus
#39 of 42Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Visit Maximus| Feature | Gala | Maximus |
|---|---|---|
| Our Score | 7/10 | 7.1/10 |
| Starting Price | $149/mo | $300/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Men who want GLP-1 alongside testosterone or other men's health protocols |
| Ranking | #40 | #39 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Maximus
Pros
- +Lowest entry price in the market — $79.99/mo microdose semaglutide, $99.99/mo 3-month starter pack
- +GLP-1 microdosing available for BMI as low as 22 — the only platform serving patients below standard obesity criteria
- +Nausea-reducing formula with added glycine and B12 to ease GLP-1 side effects
- +Free expedited shipping on all medication orders
Cons
- −Deceptive pricing structure — $99.99/mo is intro only, standard dosing is $299.99/mo with separate $28-35 consultation fees and $199-349/yr lab costs
- −Refuses to disclose compounding pharmacy partners — a transparency red flag for a healthcare platform
- −Prices increase as dose escalates on bulk plans — unpredictable total cost over time
Our Verdict
Maximus edges out Gala with a score of 7.1/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Maximus's $300/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Maximus if you want: men who want glp-1 alongside testosterone or other men's health protocols.